Aug 22, 2025 • Benzinga
SOMEWHAT-BULLISH
JANSEN HARRY KRAEMER JR's Recent Buy: Acquires $977K In Option Care Health Stock - Option Care Health ( NASDAQ:OPCH )
JANSEN HARRY KRAEMER JR, Director at Option Care Health OPCH, disclosed an insider purchase on August 21, based on a new SEC filing. What Happened: In a Form 4 filing on Thursday with the U.S. Securities and Exchange Commission, it was disclosed that JR bought 36,000 shares of Option Care Health, ...
Aug 20, 2025 • GlobeNewswire
BULLISH
Option Care Health Announces Chief Financial Officer Transition
Mike Shapiro to Step Down After 10 Years With the Company. Meenal Sethna Named EVP and CFO Effective October 1, 2025 Mike Shapiro to Step Down After 10 Years With the Company. Meenal Sethna Named EVP and CFO Effective October ...
Aug 20, 2025 • Benzinga
BULLISH
Option Care Health Announces Chief Financial Officer Transition - Option Care Health ( NASDAQ:OPCH ) , Littelfuse ( NASDAQ:LFUS )
BANNOCKBURN, Ill., Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- Option Care Health, Inc. ( the "Company" or "Option Care Health" ) OPCH, the nation's largest independent provider of home and alternate site infusion services, announced the appointment of Meenal Sethna as Executive Vice President and Chief ...
Aug 07, 2025 • Benzinga
SOMEWHAT-BULLISH
He Flipped A $140,000 Home, Launched A $175,000 Startup, Then Sold It For $12.5 Million - Now He Coaches His Kids' Soccer Team - Option Care Health ( NASDAQ:OPCH )
After flipping a $140,000 fixer-upper, Florida-based nurse-entrepreneur Nathanael Farrelly, used the profit to launch Revitalize Specialty Infusion, a startup that sent nurses to provide in-home IV treatments.
Aug 05, 2025 • Motley Fool
SOMEWHAT-BEARISH
Stock Market Today: Hims & Hers Tumbles 12% on Revenue Miss Despite 73% Growth
Hims & Hers stock fell sharply Tuesday after the company missed Q2 revenue estimates, despite strong growth and reaffirmed guidance.
Jul 31, 2025 • Motley Fool
SOMEWHAT-BULLISH
Option Care ( OPCH ) Q2 Revenue Jumps 15%
Option Care Health ( NASDAQ:OPCH ) , the leading U.S. provider of home and alternate site infusion services, reported its second-quarter 2025 results on July 30, 2025. The company reported GAAP revenue and non-GAAP earnings ahead of analyst expectations for Q2 2025, as GAAP net revenue climbed ...